How Progress Ends summary

Progress feels inevitable when you’re living through it, but history tells a different story. Look closer and you’ll see something more fragile – a process full of contradictions, sudden breakthroughs, and decades of nothing happening at all. The secret lies in recognizing that progress runs on two completely different engines that often work against each other.

The first engine is exploration. This runs on chaos – the messy, unpredictable world where new ideas emerge from nowhere. Picture thousands of experiments happening simultaneously: independent inventors in garages, university researchers following hunches, small startups betting everything on ideas that seem absurd. Most will fail. That's the point. This system sacrifices efficiency today for the possibility of doing things radically better tomorrow.

The second engine is exploitation. This runs on control, and it's where proven ideas get perfected and scaled. Think massive factories, sprawling corporations, and state industrial plans. Here, discipline replaces experimentation. The goal shifts from finding something new to making something known available to everyone, as cheaply as possible. Static efficiency becomes everything: squeeze maximum output from existing resources, optimize every process, eliminate waste.

The story of the mRNA vaccine shows both engines in action, and the friction between them.

We start with Katalin Karikó, a Hungarian biochemist whose research into mRNA was so unconventional she couldn’t get government grants. Her own colleagues thought she was wasting her time. The University of Pennsylvania denied her tenure. But she kept going anyway, convinced mRNA held therapeutic potential everyone else was missing. Her breakthrough came through pure chance – meeting immunologist Drew Weissman at a photocopier led to a collaboration that solved the fundamental problem preventing mRNA from working in human bodies.

Even after their discovery, almost nobody cared. Years passed before another scientist, Derrick Rossi, stumbled across their paper and recognized its value. He helped launch Moderna to commercialize the technology. You couldn’t have planned this trajectory if you tried. That’s how exploration works – through accidents, persistence, and countless dead ends.

Then COVID arrived, and suddenly the game changed completely.

Small innovators like BioNTech launched focused projects to develop mRNA vaccine candidates within weeks. But they needed industrial giants like Pfizer for testing, manufacturing, and distribution. Government programs like Operation Warp Speed coordinated the massive effort. The same chaotic process that created mRNA technology would have been catastrophic here. You needed hierarchy, discipline, and centralized control to save lives.

And here's where nations succeed or fail: managing the transition between these two modes. The very system that scales known technologies would have crushed Karikó's unorthodox research before it began. Powerful incumbents who've perfected exploitation have every reason to resist the creative destruction that new technologies bring. When they succeed – blocking competition or capturing regulators – progress stops.